Leonteq Securities AG’s Jaguar Health JAGX Stock Holding History

Leonteq Securities AG’s Portfolio JAGX Stock Details JAGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$15	Hold	5	–	–	﹤0.01%	1267
2026 Q1	$70	Sell	5 -1	-17%	-$22	﹤0.01%	1264
2025 Q4	$175	Hold	6	–	–	﹤0.01%	1400
2025 Q3	$438	Hold	6	–	–	﹤0.01%	1276
2025 Q2	$474	Hold	6	–	–	﹤0.01%	1221
2025 Q1	$901	Buy	+6	New	+$3.39K	﹤0.01%	1170

Other funds holding JAGX

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

IAIM

International Assets Investment Management Orlando, Florida $1.67B AUM 28.26% 1-Year Est. Return

Leonteq Securities AG's JAGX Position: Q2 2026 in Review

Leonteq Securities AG held its Jaguar Health (JAGX) position steady in Q2 2026 at 5 shares worth $15. The position accounts for ﹤0.01% of the portfolio, ranked #1267.

Leonteq Securities AG first reported a position in JAGX in Q1 2025 and has held it in 6 quarters since. The position peaked at $901 in Q1 2025. 8 funds tracked by Wall St. Rank hold JAGX as of Q2 2026.

Leonteq Securities AG held 5 shares of Jaguar Health worth $15 as of Q2 2026.
Leonteq Securities AG left its Jaguar Health share count unchanged in Q2 2026.
Jaguar Health made up ﹤0.01% of Leonteq Securities AG's portfolio in Q2 2026, its #1267 holding.
Leonteq Securities AG first reported a position in Jaguar Health in Q1 2025 and has held it in 6 quarters since.
Leonteq Securities AG's Jaguar Health position peaked at $901 in Q1 2025.
8 funds tracked by Wall St. Rank held Jaguar Health as of Q2 2026.

Based on Leonteq Securities AG's 13F filing for Q2 2026, filed 27 Jul 2026.